Table 3 Operative technique and postoperative results

N°

42

29

TT

40 (95.2 %)

21 (72.6 %)

Completion thyroidectomy

2 (4.8 %)

3 (10.4 %)

TT + CND

–

2 (6.8 %)

TT + CND + MRND ipsilateral

–

1 (3.4 %)

TT + CND + MRND bilateral

–

2 (6.8 %)

Frozen section (true positive)

2 (4.8 %)

0

Frozen section (false negative)

2 (4.8 %)

1 (3.4 %)

Mean postoperative hospital stay

(days) ± SD

3.7 ± 2.0

4.1 ± 2.5

0.520

Median (95 % CI)

3 (3.1–4.3)

3 (3.1–5.0)

Morbidity

  Transient hypocalcaemia

6 (14.2 %)

4 (13.8 %)

0.773

  Permanent hypocalcemia

–

–

  Transient unilateral laryngeal nerve palsy

–

–

  Permanent laryngeal nerve palsy

–

1 (3.4 %)

0.851

I131 ablation therapy

  0 application

–

–

–

  1 application

37 (88.1 %)

22 (76.0 %)

0.209

  2 applications

5 (11.9 %)

4 (13.8 %)

0.898

  4 applications

–

1 (3.4 %)

0.064

  5 applications

–

1 (3.4 %)

  8 applications^a

–

1 (3.4 %)

Tumor recurrence (node)

–

3 (10.4 %)

0.064

Lateral neck compartment

–

3 (10.4 %)

Central neck compartment

–

–

Loco-regional

–

1 (3.4 %)

M1 at follow-up

–

3 (10.4 %)

0.064

Overall recurrence rate

–

7 (24.1 %)

0.001

Death of thyroid cancer

–

–

Death of other causes

–

–

Mean follow-up duration (months) (range)

113 (12–288)

125 (24–196)